According to Publisher, the Global High Content Screening (HCS) software and services Market is accounted for $520.24 million in 2017 and is expected to reach $1,380.95 million by 2026 growing at a CAGR of 11.4% during the forecast period. Growing developments in informatics solutions and imaging instruments, increasing focus on cell based research and rising government support on research & development for drug discovery processes are some of the key factors driving the market growth. However, factors such as lower implementation of HCS instruments, introduction of novel image analysis instruments and rapid growth of effective purification protocols are hindering the market.
High content screening (HCS) incorporates the effectiveness of high-throughput techniques with the capacity of cellular imaging to accumulate quantitative data from complex biological systems. This technology is integrated into all aspects of contemporary drug discovery which includes, primary compound screening, post-primary screening which is capable of supporting structure-activity relationships, and early evaluation of ADME (absorption, distribution, metabolism and excretion)/toxicity properties and complex multivariate drug profiling.
Based on product, Instruments segment commanded the largest market share owing to high prices of HCS instruments and growth in advanced automation techniques. Furthermore, cell imaging and analysis systems sub-segment of HCS market is projected to grow with maximum revenue and anticipated to dominate the global market over the forecast period. In terms of geography, North America is expected to generate highest revenue due to high R&D expenditure, existence of major pharmaceutical market players and increasing government support are some of factors driving the HCS market in this region.
Some of the key players in the High Content Screening (HCS) Software and Services market are Danaher Corporation, GE Healthcare, Perkinelmer, Inc., Biotek Instruments, Inc., Yokogawa Electric Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Merck Millipore, Bio-Rad Laboratories, Inc, Tecan Group Ltd, Sysmex Corporation, Olympus Corporation and Thorlabs.
– Compound Profiling
– Toxicity Studies
– Primary and Secondary Screening
– Target Identification and Validation
– Other Applications
End User Covered:
– Contract Research Organizations
– Pharmaceutical and Biotechnology Companies
– Academic and Government Institutes
Request Sample Copy http://www.reportsweb.com/inquiry&RW00011739669/sample
Table of Contents
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global High Content Screening (HCS) Software and Services Market, By Application
6 Global High Content Screening (HCS) Software and Services Market, By Product
7 Global High Content Screening (HCS) Software and Services Market, By End User
8 Global High Content Screening (HCS) Software and Services Market, By Geography
9 Key Developments
10 Company Profiling
10.1 Danaher Corporation
10.2 GE Healthcare
10.3 Perkinelmer, Inc.
10.4 Biotek Instruments, Inc.
10.5 Yokogawa Electric Corporation
10.6 Becton, Dickinson and Company
10.7 Thermo Fisher Scientific Inc
10.8 Merck Millipore
10.9 Bio-Rad Laboratories, Inc.
10.10 Tecan Group Ltd.
10.11 Sysmex Corporation
10.12 Olympus Corporation
Make an enquiry: http://www.reportsweb.com/inquiry&RW00011739669/buying